Company / EPS (Basic)
TEVA PHARMACEUTICAL INDUSTRIES LTD EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.50
FY2025
5-year range
-$3.64 / $0.38
FY2021-FY2025
Trend
+77.3%
vs FY2024
Sector context
#69 of 208
Health Care
What the data says
At $-0.50, TEVA PHARMACEUTICAL INDUSTRIES LTD's eps (basic) ranks #69 of 208 in the Health Care sector. EPS (Basic) has fluctuated over the past 10 years, ranging from $-16.26 in FY2019 to $0.38 in FY2023.
Based on SEC 10-K filings.
-0.50 in FY2025.
Declined from $0.38 to $-0.50 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#69 of 208 in Health CareTop 33% of 208This company -$0.50 Sector average -$0.96
▼
+48.1% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 77.3% year-over-year.
- Ranks #69 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2023.
- Lowest eps (basic) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.50 | +77.3% |
| FY2024 | -$2.20 | -678.9% |
| FY2023 | $0.38 | +110.4% |
| FY2022 | -$3.64 | -300.0% |
| FY2021 | -$0.91 | +61.3% |
| FY2020 | -$2.35 | +85.5% |
| FY2019 | -$16.26 | -23328.6% |
| FY2018 | $0.07 | +100.4% |
| FY2017 | -$16.26 | -23328.6% |
| FY2016 | $0.07 | -96.2% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026